CM BIOMASS PARTNERS A/S - Group

 

Quicksearch
from your own companies




Analyst: XBRLDenmarkIFRS
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2022/4
2022
2023/4
2023
2024/4
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  5.2% 5.4% 5.3% 0.5% 0.5%  
Credit score (0-100)  44 42 41 99 98  
Credit rating  BBB BBB BBB AAA AA  
Credit limit (mEUR)  0.0 0.0 0.0 11.4 14.3  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (mEUR) 
2019
2019/12
2020
2020/12
2021
2022/4
2022
2023/4
2023
2024/4

Net sales  363 406 712 799 835  
Gross profit  15.8 23.9 54.2 60.7 51.7  
EBITDA  8.8 14.3 30.5 49.5 39.8  
EBIT  8.2 13.4 28.8 46.6 35.9  
Pre-tax profit (PTP)  8.3 13.4 30.6 34.9 45.9  
Net earnings  8.3 13.4 30.6 26.0 39.1  
Pre-tax profit without non-rec. items  8.3 13.4 30.6 34.9 45.9  

 
See the entire income statement

Balance sheet (mEUR) 
2019
2019/12
2020
2020/12
2021
2022/4
2022
2023/4
2023
2024/4

Tangible assets total  1.9 1.9 19.8 2.3 2.4  
Shareholders equity total  21.7 37.8 60.1 82.6 121  
Interest-bearing liabilities  0.0 0.0 0.0 84.9 82.2  
Balance sheet total (assets)  80.1 101 146 221 257  

Net Debt  -0.3 -1.9 -0.9 84.9 82.2  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2022/4
2022
2023/4
2023
2024/4

Net sales  363 406 712 799 835  
Net sales growth  0.0% 11.6% 75.6% 12.2% 4.6%  
Gross profit  15.8 23.9 54.2 60.7 51.7  
Gross profit growth  0.0% 51.3% 127.1% 12.0% -14.9%  
Employees  30 0 145 31 60  
Employee growth %  0.0% -100.0% 0.0% -78.6% 93.5%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  80 101 146 221 257  
Balance sheet change%  0.0% 25.9% 44.3% 51.5% 16.4%  
Added value  8.8 14.3 30.5 48.2 39.8  
Added value %  2.4% 3.5% 4.3% 6.0% 4.8%  
Investments  1 -1 16 -20 -4  

Net sales trend  0.0 1.0 2.0 3.0 4.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2022/4
2022
2023/4
2023
2024/4
EBITDA %  2.4% 3.5% 4.3% 6.2% 4.8%  
EBIT %  2.3% 3.3% 4.0% 5.8% 4.3%  
EBIT to gross profit (%)  52.2% 56.2% 53.1% 76.7% 69.4%  
Net Earnings %  2.3% 3.3% 4.3% 3.3% 4.7%  
Profit before depreciation and extraordinary items %  2.4% 3.5% 4.5% 3.6% 5.1%  
Pre tax profit less extraordinaries %  2.3% 3.3% 4.3% 4.4% 5.5%  
ROA %  10.3% 14.9% 24.8% 22.5% 23.0%  
ROI %  8.1% 11.2% 17.8% 21.9% 29.0%  
ROE %  37.9% 45.1% 62.5% 36.5% 38.5%  

Solidity 
2019
2019/12
2020
2020/12
2021
2022/4
2022
2023/4
2023
2024/4
Equity ratio %  50.0% 50.0% 48.5% 37.7% 47.1%  
Relative indebtedness %  -6.0% -9.3% -8.4% 17.3% 16.3%  
Relative net indebtedness %  -6.1% -9.8% -8.6% 17.3% 16.3%  
Net int. bear. debt to EBITDA, %  -2.9% -13.4% -2.8% 171.3% 206.6%  
Gearing %  0.0% 0.0% 0.0% 102.8% 68.1%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 14.9% 10.7%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2022/4
2022
2023/4
2023
2024/4
Quick Ratio  -1.8 -1.2 -1.1 0.5 0.9  
Current Ratio  -3.4 -2.4 -1.9 1.2 2.0  
Cash and cash equivalent  0.3 1.9 0.9 0.0 0.1  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2022/4
2022
2023/4
2023
2024/4
Trade debtors turnover (days)  0.0 0.0 0.0 22.9 23.4  
Trade creditors turnover (days)  0.0 0.0 0.0 12.7 11.6  
Current assets / Net sales %  20.6% 22.4% 15.8% 17.5% 17.7%  
Net working capital  96.7 128.6 172.9 21.9 73.6  
Net working capital %  26.6% 31.7% 24.3% 2.7% 8.8%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2022/4
2022
2023/4
2023
2024/4
Net sales / employee  12 0 5 26 14  
Added value / employee  0 0 0 2 1  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 2 1  
EBIT / employee  0 0 0 2 1  
Net earnings / employee  0 0 0 1 1